1. Microencapsulated rhEGF to facilitate epithelial healing and prevent scar formation of cesarean wound: A randomized controlled trial
- Author
-
Chuan-Chi Kao, Ting-Chang Chang, Chi-Hsin Chiang, Shin-Yin Huang, and Chih-Hui Lin
- Subjects
Adult ,medicine.medical_specialty ,Microencapsulated ,Scar assessment ,Drug Compounding ,Surgical Wound ,law.invention ,03 medical and health sciences ,chemistry.chemical_compound ,Cicatrix ,0302 clinical medicine ,Vascularity ,Silicone ,Randomized controlled trial ,Scar ,law ,Pregnancy ,medicine ,Humans ,rhEGF ,Wound Healing ,030219 obstetrics & reproductive medicine ,Epidermal Growth Factor ,business.industry ,Cesarean Section ,Recombinant human epidermal growth factor ,Obstetrics and Gynecology ,Psychological distress ,Gynecology and obstetrics ,Surgery ,medicine.anatomical_structure ,Treatment Outcome ,chemistry ,Childbearing age ,RG1-991 ,Abdomen ,Female ,medicine.symptom ,business ,Wound healing ,Gels - Abstract
Objective: Cesarean section (CS) is a major surgical intervention that affects women at childbearing age. Scarring from CS potentially causes discomfort and psychological distress. Emerging evidence indicates that epidermal growth factor (EGF) plays crucial roles in wound healing with the potential of minimizing scar formation. This study aims to investigate the effect of microencapsulated recombinant human EGF (Me-EGF) in scar prevention. Silicone gel was incorporated as part of the routine scar treatment. Materials and methods: Healthy women scheduled for cesarean delivery were enrolled and randomized to three groups: (1) no scar treatment, (2) silicone gel only, or (3) silicone gel plus Me-EGF. Vancouver Scar Scale (VSS: vascularity, pigmentation, elasticity, and height) was used for scar assessment at the 6th month and 9th month after CS. Results: A total of 60 women were enrolled, but one patient withdrew due to noncompliance with the follow-up visit requirement. Me-EGF-containing treatment group consistently scored the lowest on every parameter in the VSS scale, followed by silicone gel group, and the group with no scar treatment. Kruskal–Wallis tests indicated significant differences (p
- Published
- 2020